Skip to content

Study · Measured the body's own peptide · 1992

1 result

Erythropoietin treatment and plasma levels of corticotropin-releasing hormone, delta sleep-inducing peptide and opioid peptides in hemodialysis patients.

Hegbrant J, Thysell H, Ekman R

Scandinavian journal of urology and nephrology1 Jan 1992Cited by 5 (Europe PMC)

PMID1337953 (opens in a new tab)DOI10.3109/00365599209181232 (opens in a new tab)PepBankPUB-01337953
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelNon-randomized trialOther

    In seven hemodialysis patients, plasma levels of the body's own DSIP did not change significantly during 28 weeks of recombinant erythropoietin treatment.

    In plain wordsIn hemodialysis patients, erythropoietin treatment did not change the body's own DSIP levels in blood.

    Peptide
    Delta sleep-inducing peptide (DSIP)
    Outcome
    No significant changePlasma DSIP concentration during erythropoietin treatment
    Study

    n = 7

    Comparator
    Before r-huEPO therapy
    Outcome group
    Sleep · Nervous system and cognition

    Source sentences

    Summary
    There were no significant changes during the study in the plasma concentrations of any of the peptides measured.
    1 context sentence
    Summary · context
    In this study the plasma levels of peptides known to be involved in CNS functions, namely corticotropin-releasing hormone, delta sleep-inducing peptide, beta-endorphin, methionine-enkephalin, beta-lipotropin and alpha-melanocyte-stimulating hormone, were measured by radioimmunoassay in seven stable…

    This result measures the body's own Delta sleep-inducing peptide (DSIP). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.